CLINICAL @LERT

Dyspepsia management in the millennium: to test and treat or not?

B C Delaney

Primary Care Clinical Sciences Building, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK; b.c.delaney@bham.ac.uk

---

Test and treat followed by endoscopy for non-responders was less cost effective than empiric proton pump inhibitor (PPI) treatment followed by endoscopy or with strategies of test and treat followed by empiric PPI (or vice versa).

---

Keywords: Helicobacter pylori; decision analysis; dyspepsia; proton pump inhibitors

The first 150 words of the full text of this article appear below.

Decision analysis can be used to bridge the gap between evidence and practice. It may be used to highlight the best choice between competing management strategies where no direct trial evidence is available or add additional information, for example cost data, to extrapolate from available trial evidence.¹ The use of sensitivity analysis, changing the parameters such as the prevalence of Helicobacter pylori, is particularly helpful in establishing an "envelope" within which a particular strategy is cost effective. Trials, meta-analyses, and modelling can be seen as working together to create a practical quantified evidence base.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

Digest

Ian Forgacs
Gut 2003 52: 1. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Kuptsova, N., Kopecky, K. J., Godwin, J., Anderson, J., Hoque, A., Willman, C. L., Slovak, M. L., Ambrosone, C. B. (2007). Polymorphisms in DNA repair genes and therapeutic outcomes of AML patients from SWOG clinical trials. Blood 109: 3936-3944 [Abstract] [Full Text]  
• Corrigan, O P (2005). Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report. J. Med. Ethics 31: 144-148 [Abstract] [Full Text]  
• Mohrenweiser, H. W. (2004). Genetic Variation and Exposure Related Risk Estimation: Will Toxicology Enter a New Era? DNA Repair and Cancer as a Paradigm. Toxicol Pathol 32: 136-145 [Abstract]